Huseyin Kayadibi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Huseyin Kayadibi has a total of 138 co-authors. Here are the top co-authors by number of shared publications:
Erdim Sertoglu
Department of Medical Biochemistry, Haydarpasa Sultan Abdulhamid Training and Research Hospital, Istanbul, Turkey
7 shared publications- Ibrahim Dogan
Department of Nephrology, Hitit University, Faculty of Medicine, Çorum, Turkey
7 shared publications - Metin Uyanik
Biochemistry Laboratory, Corlu Military Hospital, Tekirdag, Turkey
7 shared publications - Erdim Sertoglu
Department of Clinical Biochemistry, Gülhane Training and Research Hospital, University of Health Sciences, Ankara, Turkey
5 shared publications - Ibrahim Ozkan Alatas
Department of Medical Biochemistry, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey
5 shared publications - Barış Eser
Department of Nephrology, Hitit University Faculty of Medicine, Çorum, Türkiye
4 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (11) , 1547
The Potential Roles of Omega Fatty Acids, Inflammation and Pre-miR-29c in Diabetic Nephropathy
Diabetic nephropathy (DN) is associated with inflammatory dysregulation and altered lipid mediators. We investigated inflammatory markers, fatty acids, and plasma pre-miR-29c in controls and type 2 diabetes mellitus (T2DM) patients stratified by albuminuria severity. This cross-sectional study included 120 T2DM patients (albumin-to-creatinine ratio, ACR: 300 mg/g; n = 40 each) and 40 controls. TNF-α, IL-6, and lipoxin A4 (LXA4) were measured by ELISA; EPA, DHA, AA, and DGLA by LC–MS/MS; and plasma pre-miR-29c by semi-quantitative endpoint RT-PCR. TNF-α was higher in all T2DM groups compared with controls. LXA4 was lower in the ACR 300 mg/g groups, while IL-6 showed no significant difference. Compared with controls, EPA was lower in both albuminuric groups, DHA was lower, and AA was higher in all T2DM groups, while DGLA remained unchanged. Plasma pre-miR-29c increased with albuminuria severity and correlated strongly with the ACR (ρ = 0.852; FDR-adjusted p < 0.001). In the final Firth model, log2-transformed pre-miR-29c was the only variable that remained statistically associated with DN (OR = 170.692, 95% CI: 22.319–23,827.669; p < 0.001); the wide confidence interval reflects near-complete separation. These exploratory findings suggest that pre-miR-29c may serve as a candidate marker of albuminuria severity, requiring confirmation by quantitative PCR with validated normalisation in longitudinal cohorts.
- 23 October 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (11) , 1547
Open AccessThe Potential Roles of Omega Fatty Acids, Inflammation and Pre-miR-29c in Diabetic Nephropathy
Diabetic nephropathy (DN) is associated with inflammatory dysregulation and altered lipid mediators. We investigated inflammatory markers, fatty acids, and plasma pre-miR-29c in controls and type 2 diabetes mellitus (T2DM) patients stratified by albuminuria severity. This cross-sectional study included 120 T2DM patients (albumin-to-creatinine ratio, ACR: 300 mg/g; n = 40 each) and 40 controls. TNF-α, IL-6, and lipoxin A4 (LXA4) were measured by ELISA; EPA, DHA, AA, and DGLA by LC–MS/MS; and plasma pre-miR-29c by semi-quantitative endpoint RT-PCR. TNF-α was higher in all T2DM groups compared with controls. LXA4 was lower in the ACR 300 mg/g groups, while IL-6 showed no significant difference. Compared with controls, EPA was lower in both albuminuric groups, DHA was lower, and AA was higher in all T2DM groups, while DGLA remained unchanged. Plasma pre-miR-29c increased with albuminuria severity and correlated strongly with the ACR (ρ = 0.852; FDR-adjusted p < 0.001). In the final Firth model, log2-transformed pre-miR-29c was the only variable that remained statistically associated with DN (OR = 170.692, 95% CI: 22.319–23,827.669; p < 0.001); the wide confidence interval reflects near-complete separation. These exploratory findings suggest that pre-miR-29c may serve as a candidate marker of albuminuria severity, requiring confirmation by quantitative PCR with validated normalisation in longitudinal cohorts.
- 1 June 2026
- Published by Caleo in Journal of Turkish Clinical Biochemistry
- Vol. 24 (1) , 7-11
Repeated Lipoprotein(a) Testing: Frequency, Risk Reclassification, and Clinical Impact
Objective: This study aimed to evaluate the frequency of repeat lipoprotein(a) testing, determine whether repeated measurements changed risk classification, assess the clinical significance of observed changes using the reference change value, and investigate whether the interval between measurements was associated with the magnitude of change. Methods: In this single-center, retrospective, observational study, laboratory records of 706 patients who had at least one lipoprotein(a) measurement between 01.12.2024 and 01.12.2025 at a tertiary care university hospital were reviewed. In patients with repeated measurements, the first and last results were compared, changes in risk classification were evaluated, and clinical significance was assessed using the reference change value. Results: Among 706 patients, 148 (21.0%) had repeated measurements. In this subgroup, the last lipoprotein(a) level was significantly lower than the first measurement. However, 92.6% of patients remained in the same risk category, while 6.8% were reclassified to a lower risk category and 0.7% to a higher risk category. The proportions of patients remaining in the same category were 99.0%, 68.8%, and 82.1% in the low-, intermediate-, and high-risk groups, respectively. In 106 paired measurements eligible for percentage-change analysis, a significant positive relationship was found between the interval between measurements and absolute percentage change. However, no patient exceeded the calculated reference change value of 58.7%. Conclusion: Repeat lipoprotein(a) testing is uncommon in routine clinical practice. Since it does not provide clinically meaningful additional information in most patients, a single measurement appears to be sufficient for most individuals. Repeat testing may be considered only in selected patients with values close to clinical decision thresholds.
- 1 June 2026
- Published by Caleo in Journal of Turkish Clinical Biochemistry
- Vol. 24 (1) , 7-11
Repeated Lipoprotein(a) Testing: Frequency, Risk Reclassification, and Clinical Impact
Objective: This study aimed to evaluate the frequency of repeat lipoprotein(a) testing, determine whether repeated measurements changed risk classification, assess the clinical significance of observed changes using the reference change value, and investigate whether the interval between measurements was associated with the magnitude of change. Methods: In this single-center, retrospective, observational study, laboratory records of 706 patients who had at least one lipoprotein(a) measurement between 01.12.2024 and 01.12.2025 at a tertiary care university hospital were reviewed. In patients with repeated measurements, the first and last results were compared, changes in risk classification were evaluated, and clinical significance was assessed using the reference change value. Results: Among 706 patients, 148 (21.0%) had repeated measurements. In this subgroup, the last lipoprotein(a) level was significantly lower than the first measurement. However, 92.6% of patients remained in the same risk category, while 6.8% were reclassified to a lower risk category and 0.7% to a higher risk category. The proportions of patients remaining in the same category were 99.0%, 68.8%, and 82.1% in the low-, intermediate-, and high-risk groups, respectively. In 106 paired measurements eligible for percentage-change analysis, a significant positive relationship was found between the interval between measurements and absolute percentage change. However, no patient exceeded the calculated reference change value of 58.7%. Conclusion: Repeat lipoprotein(a) testing is uncommon in routine clinical practice. Since it does not provide clinically meaningful additional information in most patients, a single measurement appears to be sufficient for most individuals. Repeat testing may be considered only in selected patients with values close to clinical decision thresholds.
- Open Access
- 7 March 2026
- Published by Springer Nature in BMC Ophthalmology
- Vol. 26 (1)
Serum and urinary mindin as a potential biomarker for diabetic retinopathy: a prospective cross-sectional study
To analyze the potential role of serum and urinary mindin as biomarkers for diabetic retinopathy (DR) severity in patients with type 2 diabetes mellitus (DM). This prospective, cross-sectional study included 101 participants allocated into four groups: DM without DR (n = 26), DM with non-proliferative DR (n = 25), DM with proliferative DR (n = 25), and non-diabetic healthy controls (n = 25). Serum and 24-hour urinary mindin levels were compared among the groups. Serum mindin levels were significantly lower in Group 3 than in Group 1 and Group 2 (p < 0.001 and p = 0.001, respectively). Twenty-four-hour urinary mindin levels were significantly higher in the diabetic groups (Groups 1, 2, and 3) compared to the non-diabetic control group (p = 0.046 for Group 1, p < 0.001 for Groups 2 and 3). Correlation analysis revealed positive correlations between 24-hour urinary mindin levels and DR severity, HbA1c, proteinuria, and insulin use. Multivariate logistic regression analysis established HbA1c, urinary mindin level, and proteinuria as independent determinants of DR. Conversely, the serum mindin level was not a significant predictor of DR. Twenty-four-hour urinary mindin levels were significantly higher in patients with type 2 DM than in non-diabetic healthy controls. Furthermore, urinary mindin levels increased in correlation with DR severity. In contrast, serum mindin levels were not associated with DR according to multivariate analysis.
- 7 March 2026
- Published by Springer Nature in BMC Ophthalmology
- Vol. 26 (1)
Open AccessSerum and urinary mindin as a potential biomarker for diabetic retinopathy: a prospective cross-sectional study
To analyze the potential role of serum and urinary mindin as biomarkers for diabetic retinopathy (DR) severity in patients with type 2 diabetes mellitus (DM). This prospective, cross-sectional study included 101 participants allocated into four groups: DM without DR (n = 26), DM with non-proliferative DR (n = 25), DM with proliferative DR (n = 25), and non-diabetic healthy controls (n = 25). Serum and 24-hour urinary mindin levels were compared among the groups. Serum mindin levels were significantly lower in Group 3 than in Group 1 and Group 2 (p < 0.001 and p = 0.001, respectively). Twenty-four-hour urinary mindin levels were significantly higher in the diabetic groups (Groups 1, 2, and 3) compared to the non-diabetic control group (p = 0.046 for Group 1, p < 0.001 for Groups 2 and 3). Correlation analysis revealed positive correlations between 24-hour urinary mindin levels and DR severity, HbA1c, proteinuria, and insulin use. Multivariate logistic regression analysis established HbA1c, urinary mindin level, and proteinuria as independent determinants of DR. Conversely, the serum mindin level was not a significant predictor of DR. Twenty-four-hour urinary mindin levels were significantly higher in patients with type 2 DM than in non-diabetic healthy controls. Furthermore, urinary mindin levels increased in correlation with DR severity. In contrast, serum mindin levels were not associated with DR according to multivariate analysis.
- Open Access
- 7 January 2026
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Nephrology
- Vol. 35 (1) , 32-39
Relationship of Serum Pro-Gastrin-Releasing Peptide with Kidney Fibrosis and Proteinuria
Background: Interstitial fibrosis/tubular atrophy (IFTA) plays a crucial role in the pathogenesis of chronic kidney disease. Pro-gastrin-releasing peptide (proGRP), a neuropeptide, plays a role in stimulating fibroblast activity. This study explores the association between serum proGRP levels and IFTA severity. Methods: The patient group consisted of 49 patients (23 males; mean age 44.1 ± 15 years) who underwent kidney biopsy and the control group comprised 20 healthy volunteers (8 males; mean age 43.4 ± 7.2 years). Pro-gastrin-releasing peptide was measured using a commercially available Elabscience Human Pro-Gastrin-Releasing Peptide enzyme-linked immuno sorbent assay kit. The scoring system was implemented based on the percentage of IFTA severity in kidney tissue samples. Results: Pro-gastrin-releasing peptide levels were observed to be significantly elevated in the patient group compared to the controls [30.0 (22.1-48.1) U/L vs 19.7 (15.1-30.3) U/L, (P = .004)]. A statistically significant positive correlation was identi fied between proGRP level and the presence of proteinuria (P = .012). Conclusion: The study demonstrated that proGRP levels might increase in the presence of kidney fibrosis and proteinuria. Cite this article as: Özden M, Eser B, Doğan I, et al. Relationship of serum pro-gastrin-releasing peptide with kidney fibrosis and proteinuria. Turk J Nephrol. 2026;35(1):32-39.
- 7 January 2026
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Nephrology
- Vol. 35 (1) , 32-39
Open AccessRelationship of Serum Pro-Gastrin-Releasing Peptide with Kidney Fibrosis and Proteinuria
Background: Interstitial fibrosis/tubular atrophy (IFTA) plays a crucial role in the pathogenesis of chronic kidney disease. Pro-gastrin-releasing peptide (proGRP), a neuropeptide, plays a role in stimulating fibroblast activity. This study explores the association between serum proGRP levels and IFTA severity. Methods: The patient group consisted of 49 patients (23 males; mean age 44.1 ± 15 years) who underwent kidney biopsy and the control group comprised 20 healthy volunteers (8 males; mean age 43.4 ± 7.2 years). Pro-gastrin-releasing peptide was measured using a commercially available Elabscience Human Pro-Gastrin-Releasing Peptide enzyme-linked immuno sorbent assay kit. The scoring system was implemented based on the percentage of IFTA severity in kidney tissue samples. Results: Pro-gastrin-releasing peptide levels were observed to be significantly elevated in the patient group compared to the controls [30.0 (22.1-48.1) U/L vs 19.7 (15.1-30.3) U/L, (P = .004)]. A statistically significant positive correlation was identi fied between proGRP level and the presence of proteinuria (P = .012). Conclusion: The study demonstrated that proGRP levels might increase in the presence of kidney fibrosis and proteinuria. Cite this article as: Özden M, Eser B, Doğan I, et al. Relationship of serum pro-gastrin-releasing peptide with kidney fibrosis and proteinuria. Turk J Nephrol. 2026;35(1):32-39.
- 30 December 2025
- Published by Caleo in Turkish Society of Clinical Biochemistry
- Vol. 23 (3) , 139-142
A Case of Unexpected Elevated Bilirubin Levels in Urine
Tam idrar analizi diyabet, karaciğer veya üriner sistem hastalıkları, hidrasyon, idrar yolu enfeksiyonları ve birçok klinik durum hakkında önemli bilgiler sağladığı için klinisyenler tarafından sıklıkla istenir. Tam idrar analizi sonuçları diyet, gıda takviyeleri ve ilaç tedavileri dahil olmak üzere birçok faktörden etkilenebilir. Bu vaka sunumunda idrarda etodolak etken maddeli antienflamatuvar bir ilaç alımı kaynaklı yanlış pozitif idrar bilirubin vakası sunuldu.
- 30 December 2025
- Published by Caleo in Turkish Society of Clinical Biochemistry
- Vol. 23 (3) , 139-142
A Case of Unexpected Elevated Bilirubin Levels in Urine
Tam idrar analizi diyabet, karaciğer veya üriner sistem hastalıkları, hidrasyon, idrar yolu enfeksiyonları ve birçok klinik durum hakkında önemli bilgiler sağladığı için klinisyenler tarafından sıklıkla istenir. Tam idrar analizi sonuçları diyet, gıda takviyeleri ve ilaç tedavileri dahil olmak üzere birçok faktörden etkilenebilir. Bu vaka sunumunda idrarda etodolak etken maddeli antienflamatuvar bir ilaç alımı kaynaklı yanlış pozitif idrar bilirubin vakası sunuldu.
- 27 November 2025
- Published by Elsevier in Toxicology Letters
- Vol. 414, 111782
Comparison of the serum levels of proteins involved in microtubule stabilization in patients with alcohol or heroin use disorder
- 27 November 2025
- Published by Elsevier in Toxicology Letters
- Vol. 414, 111782
Comparison of the serum levels of proteins involved in microtubule stabilization in patients with alcohol or heroin use disorder
- 17 November 2025
- Published by Springer Nature in Pediatric Nephrology
- Vol. 41 (3) , 765-772
Relationships between galectin-3, sclerostin and arterial stiffness in children with renal scar
Background Renal scar can lead to hypertension and cardiovascular disease in children. Arterial stiffness is an important endpoint in the development of cardiovascular diseases and is a guide in the recognition of subclinical cardiovascular events. This study aimed to investigate oscillometric arterial stiffness data and sclerostin and galectin-3 levels in children with renal scar. Methods Patients aged 5–18 years with renal scar and controls were included. Arterial stiffness parameters were measured by oscillometric method. Sclerostin, galectin-3 and NGAL levels were determined by ELISA method. Results 108 patients and 66 controls were included. The patients had higher C-reactive protein (CRP) values and lower glomerular filtration rate (GFR) (p = 0.013, p = 0.005, respectively). Serum sclerostin levels, urine NGAL/creatinine (cr) and sclerostin/cr, galectin-3/cr, augmentation index, reflection magnitude and augmentation pressure were higher in patients (p = 0.026, p = 0.047, p = 0.000, p = 0.000, p = 0.013, p = 0.03, p = 0.02, respectively). Serum sclerostin was positively correlated with CRP and augmentation index (r = 0.22, p = 0.044; r = 0.355, p = 0.003, respectively). Urinary galectin-3/cr and NGAL/cr values were positively correlated with each other (r = 0.544, p = 0.000). Urinary galectin-3/cr was higher in patients with proteinuria than in those without proteinuria (p = 0.000). A ROC analysis showed that galectin-3/cr was predictive of proteinuria (area under the curve:0.726 ± 0.075, p = 0.048). Conclusion The detection of higher augmentation index and reflection magnitude in scarred patients might support the onset of subclinical atherosclerosis in these children. Higher serum sclerostin levels in scarred patients might be due to increased inflammation or arterial stiffness. Urinary galectin-3/cr could be used as tubular damage markers. Graphical abstract A higher resolution version of the Graphical abstract is available as Supplementary information
- 17 November 2025
- Published by Springer Nature in Pediatric Nephrology
- Vol. 41 (3) , 765-772
Relationships between galectin-3, sclerostin and arterial stiffness in children with renal scar
Background Renal scar can lead to hypertension and cardiovascular disease in children. Arterial stiffness is an important endpoint in the development of cardiovascular diseases and is a guide in the recognition of subclinical cardiovascular events. This study aimed to investigate oscillometric arterial stiffness data and sclerostin and galectin-3 levels in children with renal scar. Methods Patients aged 5–18 years with renal scar and controls were included. Arterial stiffness parameters were measured by oscillometric method. Sclerostin, galectin-3 and NGAL levels were determined by ELISA method. Results 108 patients and 66 controls were included. The patients had higher C-reactive protein (CRP) values and lower glomerular filtration rate (GFR) (p = 0.013, p = 0.005, respectively). Serum sclerostin levels, urine NGAL/creatinine (cr) and sclerostin/cr, galectin-3/cr, augmentation index, reflection magnitude and augmentation pressure were higher in patients (p = 0.026, p = 0.047, p = 0.000, p = 0.000, p = 0.013, p = 0.03, p = 0.02, respectively). Serum sclerostin was positively correlated with CRP and augmentation index (r = 0.22, p = 0.044; r = 0.355, p = 0.003, respectively). Urinary galectin-3/cr and NGAL/cr values were positively correlated with each other (r = 0.544, p = 0.000). Urinary galectin-3/cr was higher in patients with proteinuria than in those without proteinuria (p = 0.000). A ROC analysis showed that galectin-3/cr was predictive of proteinuria (area under the curve:0.726 ± 0.075, p = 0.048). Conclusion The detection of higher augmentation index and reflection magnitude in scarred patients might support the onset of subclinical atherosclerosis in these children. Higher serum sclerostin levels in scarred patients might be due to increased inflammation or arterial stiffness. Urinary galectin-3/cr could be used as tubular damage markers. Graphical abstract A higher resolution version of the Graphical abstract is available as Supplementary information
- 5 April 2025
- Published by Springer Nature in International Urology and Nephrology
- Vol. 57 (9) , 3019-3028
The relationship between serum salusins levels and atherosclerosis, endothelial dysfunction and cardiac morphology in autosomal dominant polycystic kidney disease
Purpose We aimed to assess the associations between serum salusins levels and atherosclerosis, endothelial dysfunction and cardiac morphology in autosomal dominant polycystic kidney disease (ADPKD). Methods This study comprised 83 patients with ADPKD, and 53 healthy individuals. Salusin α and β levels were measured by ELISA. Echocardiography, flow-mediated vasodilatation, and carotid artery intima–media thickness measurements were conducted. Results Serum salusin α levels were significantly lower and the salusin β/α ratio was significantly higher in the patient group compared to Controls [2.64 (1.83–3.30) pg/mL vs. 3.20 (2.55–7.87) pg/mL, P = 0.002 and 2.81 (2.30–3.54) vs. 2.64 (2.02–3.18), P = 0.041, respectively]. Patients were further categorized into two groups: Group 1 (eGFR ≥ 60 mL/min/1.73 m2) and Group 2 (eGFR = 59–15 mL/min/1.73 m2). The salusin α level was 2.31 (1.73–3.24) pg/mL in Group 2 and 2.72 (1.94–3.32) pg/mL in Group 1. In the correlation analysis performed in Group 2, there was a statistically significant negative correlation between salusin α and left ventricular mass (LVM) and LVM index (P = 0.019, P = 0.015, respectively), as well as a statistically significant positive correlation between salusin β/α ratio and LVM (P = 0.004) and LVM index (P = 0.025). In Group 1, a statistically significant positive correlation was detected between proteinuria and salusin β (P = 0.036). Conclusion In patients with ADPKD, salusin α was found to be significantly lower, while salusin β/α ratio was found to be significantly higher compared to healthy individuals. Low salusin α levels and high salusin β/α ratio were associated with LVM in advanced stages of ADPKD and salusin β was associated with proteinuria in early stage of ADPKD patients.
- 5 April 2025
- Published by Springer Nature in International Urology and Nephrology
- Vol. 57 (9) , 3019-3028
The relationship between serum salusins levels and atherosclerosis, endothelial dysfunction and cardiac morphology in autosomal dominant polycystic kidney disease
Purpose We aimed to assess the associations between serum salusins levels and atherosclerosis, endothelial dysfunction and cardiac morphology in autosomal dominant polycystic kidney disease (ADPKD). Methods This study comprised 83 patients with ADPKD, and 53 healthy individuals. Salusin α and β levels were measured by ELISA. Echocardiography, flow-mediated vasodilatation, and carotid artery intima–media thickness measurements were conducted. Results Serum salusin α levels were significantly lower and the salusin β/α ratio was significantly higher in the patient group compared to Controls [2.64 (1.83–3.30) pg/mL vs. 3.20 (2.55–7.87) pg/mL, P = 0.002 and 2.81 (2.30–3.54) vs. 2.64 (2.02–3.18), P = 0.041, respectively]. Patients were further categorized into two groups: Group 1 (eGFR ≥ 60 mL/min/1.73 m2) and Group 2 (eGFR = 59–15 mL/min/1.73 m2). The salusin α level was 2.31 (1.73–3.24) pg/mL in Group 2 and 2.72 (1.94–3.32) pg/mL in Group 1. In the correlation analysis performed in Group 2, there was a statistically significant negative correlation between salusin α and left ventricular mass (LVM) and LVM index (P = 0.019, P = 0.015, respectively), as well as a statistically significant positive correlation between salusin β/α ratio and LVM (P = 0.004) and LVM index (P = 0.025). In Group 1, a statistically significant positive correlation was detected between proteinuria and salusin β (P = 0.036). Conclusion In patients with ADPKD, salusin α was found to be significantly lower, while salusin β/α ratio was found to be significantly higher compared to healthy individuals. Low salusin α levels and high salusin β/α ratio were associated with LVM in advanced stages of ADPKD and salusin β was associated with proteinuria in early stage of ADPKD patients.
- 30 December 2024
- Published by Caleo in Turkish Society of Clinical Biochemistry
- Vol. 22 (3) , 133-142
Is Capillary Zone Electrophoresis a Reliable Alternative for BCG-Based Albumin Measurement
Amaç: Bu çalışmanın amacı, kapiller zon elektroforezi (CZE) yöntemi ile bromokrezol yeşili (BCG) yöntemine dayalı albümin ölçümlerinin uyumunu değerlendirmek ve bu yöntemlerin klinik uygulamalarda birbirinin yerine kullanılıp kullanılamayacağını belirlemektir. Çalışma ayrıca, albümin ölçüm sonuçlarının farklı protein paternlerine göre nasıl değişkenlik gösterdiğini incelemiştir. Gereç ve Yöntem: CZE ve BCG yöntemleriyle albümin konsantrasyonları 373 hastada ölçüldü. Albümin ve total protein seviyeleri, IgG konsantrasyonları, gama bandı yüzdesi ve M protein konsantrasyonları analiz edilerek alt gruplar oluşturuldu. İki yöntem arasındaki uyum Bland-Altman analizi ile değerlendirildi. Sabit, oransal ve rastgele hatalar Passing-Bablok regresyonu ile analiz edildi. Klinik anlamlılık, toplam kabul edilebilir hata (TEa) ile toplam analitik hata (TAE) değerlerinin karşılaştırılmasıyla değerlendirildi. Bulgular: CZE yöntemi, albümin düzeylerini BCG yöntemine kıyasla ortalama 0.28 g/dL daha düşük ölçtü. Düşük albümin seviyelerinde (%12.5) daha yüksek yanlılık saptandı. Sabit, orantılı ve rastgele hataların mevcut olduğu görüldü. Alt grup analizleri, TAE’nin TEa’yı aştığını ortaya koydu. Sonuç: CZE ve BCG yöntemleri arasında belirgin analitik hatalar saptanmış ve bu yöntemlerin birbirinin yerine kullanımı önerilmemiştir. Farklı protein paternlerinde yapılan detaylı alt grup analizleri, bu uyumsuzluğun tutarlı bir şekilde devam ettiğini göstermiştir. Bulgular, CZE yönteminin klinik karar süreçlerinde dikkatle değerlendirilmesi gerektiğini açıkça vurgulamaktadır.
- 30 December 2024
- Published by Caleo in Turkish Society of Clinical Biochemistry
- Vol. 22 (3) , 133-142
Is Capillary Zone Electrophoresis a Reliable Alternative for BCG-Based Albumin Measurement
Amaç: Bu çalışmanın amacı, kapiller zon elektroforezi (CZE) yöntemi ile bromokrezol yeşili (BCG) yöntemine dayalı albümin ölçümlerinin uyumunu değerlendirmek ve bu yöntemlerin klinik uygulamalarda birbirinin yerine kullanılıp kullanılamayacağını belirlemektir. Çalışma ayrıca, albümin ölçüm sonuçlarının farklı protein paternlerine göre nasıl değişkenlik gösterdiğini incelemiştir. Gereç ve Yöntem: CZE ve BCG yöntemleriyle albümin konsantrasyonları 373 hastada ölçüldü. Albümin ve total protein seviyeleri, IgG konsantrasyonları, gama bandı yüzdesi ve M protein konsantrasyonları analiz edilerek alt gruplar oluşturuldu. İki yöntem arasındaki uyum Bland-Altman analizi ile değerlendirildi. Sabit, oransal ve rastgele hatalar Passing-Bablok regresyonu ile analiz edildi. Klinik anlamlılık, toplam kabul edilebilir hata (TEa) ile toplam analitik hata (TAE) değerlerinin karşılaştırılmasıyla değerlendirildi. Bulgular: CZE yöntemi, albümin düzeylerini BCG yöntemine kıyasla ortalama 0.28 g/dL daha düşük ölçtü. Düşük albümin seviyelerinde (%12.5) daha yüksek yanlılık saptandı. Sabit, orantılı ve rastgele hataların mevcut olduğu görüldü. Alt grup analizleri, TAE’nin TEa’yı aştığını ortaya koydu. Sonuç: CZE ve BCG yöntemleri arasında belirgin analitik hatalar saptanmış ve bu yöntemlerin birbirinin yerine kullanımı önerilmemiştir. Farklı protein paternlerinde yapılan detaylı alt grup analizleri, bu uyumsuzluğun tutarlı bir şekilde devam ettiğini göstermiştir. Bulgular, CZE yönteminin klinik karar süreçlerinde dikkatle değerlendirilmesi gerektiğini açıkça vurgulamaktadır.
- 3 May 2023
- Published by Caleo in Turkish Society of Clinical Biochemistry
- Vol. 21 (1) , 069-074
Toksikolojik Analizlerde Kullanılan Analitik Teknikler
Toksikolojik analizler toksik ve yasadışı maddelerin tespiti, ilişkili olduğu hastalıkların tanı, takip ve tedavisinin değerlendirilmesi için yapılır. Numune türü olarak idrar, serum, plazma, kan, saç, tükürük, ter, tırnak, mide aspiratı ve içerisinde yabancı bir maddenin arandığı her türlü katı veya sıvı kullanılır. Bu analizlerdeki tarama yöntemleri hızlı, ucuz, yüksek hassasiyetli ve düşük özgüllüklü iken, doğrulama yöntemleri yavaş, pahalı, yüksek hassasiyet ve özgüllüklüdür. Tarama yöntemleri başlıca immunoassayler ve kromatografik teknikler olup negatif örnekleri pozitif örneklerden ayırmak için, doğrulama yöntemleri ise tarama testlerinde pozitif çıkan sonuçların doğrulanması için kullanılır. Altın standart doğrulama yöntemi kütle spektrometridir. Immunoassayler özgül olmadığı için çapraz reaksiyonlar görülebilir. Yüksek basınçlı sıvı kromatografi polar ve uçucu olmayan örnekler için uygun iken, gaz kromatografi uçucu örnekler için uygundur. Gaz kromatografi kütle spektrometri yöntemi immunoassay ve yüksek basınçlı sıvı kromatografi tekniğinden daha sensitif iken örnek hazırlama süresi daha uzundur. Çünkü separasyon için maddeler ve metabolitleri genellikle az polar ve daha uçucu türevlerine dönüştürülür. Sıvı kromatografi sıralı kütle spektrometri tekniğinin ise özgüllüğü ve duyarlılığı yüksektir, ancak analizi komplekstir, deneyimli personel gerekir ve maliyeti yüksektir. Toksikolojik analizler için yeterli olabilen tek bir analitik teknik yoktur. Birden fazla tekniğin kombine edilmesi önerilir.
- 3 May 2023
- Published by Caleo in Turkish Society of Clinical Biochemistry
- Vol. 21 (1) , 069-074
Toksikolojik Analizlerde Kullanılan Analitik Teknikler
Toksikolojik analizler toksik ve yasadışı maddelerin tespiti, ilişkili olduğu hastalıkların tanı, takip ve tedavisinin değerlendirilmesi için yapılır. Numune türü olarak idrar, serum, plazma, kan, saç, tükürük, ter, tırnak, mide aspiratı ve içerisinde yabancı bir maddenin arandığı her türlü katı veya sıvı kullanılır. Bu analizlerdeki tarama yöntemleri hızlı, ucuz, yüksek hassasiyetli ve düşük özgüllüklü iken, doğrulama yöntemleri yavaş, pahalı, yüksek hassasiyet ve özgüllüklüdür. Tarama yöntemleri başlıca immunoassayler ve kromatografik teknikler olup negatif örnekleri pozitif örneklerden ayırmak için, doğrulama yöntemleri ise tarama testlerinde pozitif çıkan sonuçların doğrulanması için kullanılır. Altın standart doğrulama yöntemi kütle spektrometridir. Immunoassayler özgül olmadığı için çapraz reaksiyonlar görülebilir. Yüksek basınçlı sıvı kromatografi polar ve uçucu olmayan örnekler için uygun iken, gaz kromatografi uçucu örnekler için uygundur. Gaz kromatografi kütle spektrometri yöntemi immunoassay ve yüksek basınçlı sıvı kromatografi tekniğinden daha sensitif iken örnek hazırlama süresi daha uzundur. Çünkü separasyon için maddeler ve metabolitleri genellikle az polar ve daha uçucu türevlerine dönüştürülür. Sıvı kromatografi sıralı kütle spektrometri tekniğinin ise özgüllüğü ve duyarlılığı yüksektir, ancak analizi komplekstir, deneyimli personel gerekir ve maliyeti yüksektir. Toksikolojik analizler için yeterli olabilen tek bir analitik teknik yoktur. Birden fazla tekniğin kombine edilmesi önerilir.